Tetanus Clinical Trials

• Tetanus Immunization in Subjects With No Immunization History or With Tetanus Antibody Levels Below Protective Levels
  ClinicalTrials.gov Identifier: NCT00437671 - Recruiting
  Tetanus
  
• Immunogenicity and Safety of PENTAXIM™ in Indian Population
  ClinicalTrials.gov Identifier: NCT00259337 - Active, not recruiting
  Diphtheria; Tetanus; Polio; Pertussis; Haemophilus Influenzae Type B
  
• Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children with Weakened Immune Systems
  ClinicalTrials.gov Identifier: NCT00006066 - Active, not recruiting
  HIV Infections
  
• Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents
  ClinicalTrials.gov Identifier: NCT00325130 - Active, not recruiting
  Neoplasms, Glandular and Epithelial; Diphtheria; Tetanus; Whooping Cough; Meningitis
  
• Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents
  ClinicalTrials.gov Identifier: NCT00337428 - Active, not recruiting
  Neoplasms, Glandular and Epithelial; Diphtheria; Tetanus; Whooping Cough; Poliomyelitis
  
• Post-Marketing Safety Study of GSK Biological''s Pediarix™ Vaccine.
  ClinicalTrials.gov Identifier: NCT00146835 - Active, not recruiting
  Prophylaxis: Diphtheria, tetanus, pertussis, hepatitis B, poliovirus type 1, type 2 and type 3
  
• Pilot Study Freeze and Transport Immune Cells
  ClinicalTrials.gov Identifier: NCT00138268 - Active, not recruiting
  Diphtheria; Hepatitis B; Pertussis; Poliomyelitis; Tetanus
  
• Vaccination with tetanus and KLH to assess immune responses.
  ClinicalTrials.gov Identifier: NCT00000105 - Recruiting
  Cancer
  
• Study of an Investigational Vaccine in Healthy Infants in Taiwan
  ClinicalTrials.gov Identifier: NCT00092469 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Poliomyelitis
  
• Immunogenicity and Safety of ADACEL™ in Taiwan
  ClinicalTrials.gov Identifier: NCT00258908 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis
  
• Vaccine Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00003224 - Active, not recruiting
  Stage IV Melanoma; stage II melanoma; stage III melanoma; Recurrent Melanoma
  
• REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-Old Children
  ClinicalTrials.gov Identifier: NCT00447525 - Active, not recruiting
  Diphtheria; Tetanus; Poliomyelitis
  
• Combined Tdap (Tetanus, Diphtheria, acellular Pertussis) Vaccine Used As A Booster Compared To Licensed Td (Tetanus and Diphtheria) Vaccine
  ClinicalTrials.gov Identifier: NCT00109330 - Completed
  Diphtheria; Tetanus; Pertussis
  
• Post-Marketing Safety Study of GSK Biologicals' Boostrix® Vaccine.
  ClinicalTrials.gov Identifier: NCT00297856 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis
  
• Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV
  ClinicalTrials.gov Identifier: NCT00319852 - Active, not recruiting
  Pertussis; Diphtheria; Poliomyelitis; Tetanus
  
• Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines
  ClinicalTrials.gov Identifier: NCT00254917 - Active, not recruiting
  Diphtheria; Tetanus; Polio; Pertussis; Haemophilus Influenzae Type B
  
• Immunogenicity and Safety of Pentaxim in South African Infants
  ClinicalTrials.gov Identifier: NCT00254969 - Active, not recruiting
  Diphtheria; Tetanus; Haemophilus Infections; Pertussis; Poliomyelitis
  
• Descriptive, Open-Label, Multicenter Study of the Safety of Redosing With ADACEL Vaccine
  ClinicalTrials.gov Identifier: NCT00347958 - Active, not recruiting
  Tetanus; Diphtheria; Pertussis
  
• Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00027833 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum
  
• Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand
  ClinicalTrials.gov Identifier: NCT00255021 - Active, not recruiting
  Diphtheria; Tetanus; Poliomyelitis; Haemophilus Infections; Pertussis
  
• Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®
  ClinicalTrials.gov Identifier: NCT00355121 - Active, not recruiting
  Meningococcal Meningitis; Tetanus; Diphtheria; Pertussis; Poliomyelitis
  
• Post-Licensure, Modified Double-Blind, Multi-Center Study Evaluating Safety and Immunogenicity of ADACEL and BOOSTRIX
  ClinicalTrials.gov Identifier: NCT00319553 - Active, not recruiting
  Pertussis; Tetanus; Diphtheria
  
• Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants
  ClinicalTrials.gov Identifier: NCT00303316 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Poliomyelitis; Hepatitis B
  
• Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers
  ClinicalTrials.gov Identifier: NCT00343421 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Poliomyelitis; Haemophilus Influenzae Type B
  
• Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months
  ClinicalTrials.gov Identifier: NCT00453570 - Active, not recruiting
  Diphtheria; Tetanus; Haemophilus Influenzae Type B; Pertussis; Poliomyelitis
  
• Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®
  ClinicalTrials.gov Identifier: NCT00258895 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis
  
• Post-Marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine
  ClinicalTrials.gov Identifier: NCT00304265 - Active, not recruiting
  Pertussis; Diphtheria; Tetanus; Poliomyelitis
  
• Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants
  ClinicalTrials.gov Identifier: NCT00287092 - Active, not recruiting
  Pertussis; Diphtheria; Tetanus; Poliomyelitis; Haemophilus Influenzae Type B
  
• Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants
  ClinicalTrials.gov Identifier: NCT00404651 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Poliomyelitis
  
• Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar®
  ClinicalTrials.gov Identifier: NCT00362427 - Active, not recruiting
  Diphtheria; Pertussis; Polio; Hepatitis B; Tetanus
  
• Study Comparing a DTaP HB PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants
  ClinicalTrials.gov Identifier: NCT00348881 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Influenza
  
• Safety of DTaP-IPV-HB-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.
  ClinicalTrials.gov Identifier: NCT00313911 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type B; Hepatitis B
  
• Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine
  ClinicalTrials.gov Identifier: NCT00343889 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Haemophilus Infections
  
• Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACWY at 24 to 30 m in Primed Subjects
  ClinicalTrials.gov Identifier: NCT00317109 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Haemophilus Infections; Meningococcal Infections
  
• Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.
  ClinicalTrials.gov Identifier: NCT00548171 - Recruiting
  Diphtheria; Tetanus; Pertussis
  
• Descriptive, Post-Marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine
  ClinicalTrials.gov Identifier: NCT00258882 - Active, not recruiting
  Pertussis
  
• Prevention of GBS Colonization Via Immun
  ClinicalTrials.gov Identifier: NCT00128219 - Active, not recruiting
  Streptococcus group B
  
• Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine
  ClinicalTrials.gov Identifier: NCT00514059 - Completed
  Diphtheria; Tetanus; Pertussis; Polio
  
• To Assess the Immune Response Following Primary Vaccination with Two Formulations of DTPw-HBV Vaccine When Given with Rotavirus Vaccine to Infants at 3, 4½ and 6 Months of Age.
  ClinicalTrials.gov Identifier: NCT00158756 - Completed
  Prophylaxis of diphtheria, tetanus, pertussis and hepatitis B diseases
  
• Trial to Evaluate the Safety and Immunogenicity of a Single Dose of ADACEL Vaccine in Persons => 65 Years of Age
  ClinicalTrials.gov Identifier: NCT00457249 - Recruiting
  Pertussis; Tetanus; Diphtheria
  
• Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine
  ClinicalTrials.gov Identifier: NCT00164411 - Active, not recruiting
  Pneumococcal Infections
  
• Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Diphtheria, Tetanus & Pertussis Vaccine (DTaP) Vaccine & a Haemophilus Influenza Type B (Hib) Vaccine in Healthy Children 15 m of Age
  ClinicalTrials.gov Identifier: NCT00197236 - Active, not recruiting
  Hepatitis A
  
• Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2
  ClinicalTrials.gov Identifier: NCT00050726 - Active, not recruiting
  HIV Infections
  
• Non-Inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib
  ClinicalTrials.gov Identifier: NCT00473668 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Haemophilus Influenzae Type b Diseases
  
• Randomised Study of Not Giving Diphteria-Tetanus-Pertussis Vaccination With or After Measles Vaccination
  ClinicalTrials.gov Identifier: NCT00244673 - Recruiting
  Mortality; Hospitalisation; Adverse Events
  
• Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age
  ClinicalTrials.gov Identifier: NCT00467519 - Recruiting
  Tetanus; Diphtheria; Pertussis
  
• Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly
  ClinicalTrials.gov Identifier: NCT00432042 - Recruiting
  Varicella; Measles; Mumps; Rubella; Diphtheria; Tetanus; Pertussis; Poliomyelitis; Hepatitis B; Haemophilus Infections
  
• Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP HB PRP~T Combined Vaccine in Filipino Infants
  ClinicalTrials.gov Identifier: NCT00514709 - Recruiting
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Heamophilus Influenza
  
• Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™
  ClinicalTrials.gov Identifier: NCT00534833 - Recruiting
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Haemophilus Influenzae Type B
  
• Comparison of Three Lots of GSK Biologicals'' DTaP-IPV Candidate Vaccine to DTaP and IPV Administered Separately in Terms of Immune Response and Safety.
  ClinicalTrials.gov Identifier: NCT00148941 - Completed
  Prophylaxis: Diphtheria, tetanus, pertussis, poliovirus type 1, type 2 and type 3
  
• To Assess the Immune Memory Following Primary Vaccination with a Formulation of DTPw-HBV/Hib Vaccine and to Assess Immunogenicity and Reactogenicity of a Booster Dose Given at 15-18 Months of Age.
  ClinicalTrials.gov Identifier: NCT00158808 - Completed
  Prophylaxis of Diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenza type b diseases
  
• Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Given to Healthy Children 15 Months of Age
  ClinicalTrials.gov Identifier: NCT00289913 - Recruiting
  Hepatitis A
  
• Booster Vaccination Study to Assess Immune Response & Safety of a Dose of GSK Biologicals’ Mencevax™ ACWY at 24-30 Mths Age & to Assess Immune Response & Safety of 1/5th of a Dose of Mencevax™ ACWY at 30-36 Mths Age in Subjects Primed in
  ClinicalTrials.gov Identifier: NCT00291343 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Hib Diseases; Neisseria Meningitidis Serogroups A & C Diseases
  
• Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00013871 - Active, not recruiting
  HIV Infections; Hepatitis B; Measles; Pneumococcal Infections; Pertussis
  
• Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00003222 - Active, not recruiting
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy with Or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, Or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00118313 - Active, not recruiting
  stage II melanoma; stage III melanoma; Stage IV Melanoma
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines
  ClinicalTrials.gov Identifier: NCT00004800 - Completed
  Pertussis
  
• Immunogenicity & Safety Study to Evaluate the Response to a Booster Dose of GSK Biologicals'' Tritanrix™-HepB/Hib-MenAC Vaccine at 15-24 Months and to Evaluate the Response to Mencevax™ ACWY at 24-30 Months in Healthy Children Primed with
  ClinicalTrials.gov Identifier: NCT00136604 - Completed
  Prophylaxis diphtheria, tetanus, pertussis, hepatits B, Haemophilus influenzae type b and meningococcal serogroup A & C disease
  
• Study to Demonstrate the Lot-to-Lot Consistency of Hib-MenAC When Mixed with Tritanrix™-HepB, and to Demonstrate Its Non-Inferiority as Compared to Tritanrix™-HepB/Hiberix™ in Infants at 2, 4&6 m
  ClinicalTrials.gov Identifier: NCT00197275 - Completed
  Prophylaxis diphtheria, tetanus, pertussis, hepatitis B, Haemophilus influenzae type b and meningococcal serogroups A and C diseases
  
• Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00071981 - Recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy with Or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, Or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00118274 - Recruiting
  stage II melanoma; stage III melanoma; Stage IV Melanoma
  
• Study to Assess the Safety & Reactogenicity of GSK Biologicals’ dTpa Vaccine (Boostrix) When Given at 6-8 Years of Age.
  ClinicalTrials.gov Identifier: NCT00406562 - Completed
  Diphtheria; Tetanus; Pertussis
  
• Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age
  ClinicalTrials.gov Identifier: NCT00376779 - Completed
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Poliomyelitis; Haemophilus Infections
  
• Studies of In Vitro B Lymphocyte Responses in Subjects Receiving Tetanus Toxoid Booster Immunization
  ClinicalTrials.gov Identifier: NCT00001173 - Completed
  Healthy
  
• Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines.
  ClinicalTrials.gov Identifier: NCT00544271 - Completed
  Diphtheria; Tetanus; Pertussis; Hepatitis A
  
• Persistence Study of GSK Bio's Tdap Vaccine 1, 3, 5 and 10 Years After Administration as a Single Dose in 106316 Study
  ClinicalTrials.gov Identifier: NCT00489970 - Completed
  Diphtheria; Tetanus; Pertussis
  
• Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT Vaccine
  ClinicalTrials.gov Identifier: NCT00452686 - Completed
  Diphtheria; Tetanus; Pertussis
  
• Study to Assess the Safety & Reactogenicity of GSK Biologicals’ DTPa/Hib Vaccine When Given at 3, 4 and 5 Months of Age
  ClinicalTrials.gov Identifier: NCT00379977 - Completed
  Diphtheria; Tetanus; Pertussis; Hib Diseases
  
• Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants
  ClinicalTrials.gov Identifier: NCT00169442 - Completed
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Hib Diseases
  
• Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants
  ClinicalTrials.gov Identifier: NCT00320463 - Completed
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Poliomyelitis; Haemophilus Influenza Type b Disease
  
• Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age.
  ClinicalTrials.gov Identifier: NCT00316680 - Completed
  Prophylaxis for Diphtheria; Tetanus; Pertussis; Hepatitis B; Haemophilus Influenzae Type b Diseases
  
• US-Licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-Licensed Vaccine Against Meningococcal Disease
  ClinicalTrials.gov Identifier: NCT00282295 - Completed
  Healthy
  
• A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects.
  ClinicalTrials.gov Identifier: NCT00317174 - Completed
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Hib Diseases; Neisseria Meningitidis Serogroups A & C Diseases
  
• Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib.
  ClinicalTrials.gov Identifier: NCT00412854 - Completed
  Diphtheria; Tetanus; Pertussis; Haemophilus Influenza Type b Disease
  
• Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults
  ClinicalTrials.gov Identifier: NCT00385255 - Completed
  Diphtheria; Tetanus; Pertussis; Influenza
  
• Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-Containing Vaccine.
  ClinicalTrials.gov Identifier: NCT00263679 - Completed
  Prophylaxis: Diphtheria, Tetanus and Pertussis
  
• Safety Study of Tritanrix™-HepB/Hib-MenAC, Tritanrix™-HepB/Hiberix™, and Mencevax™ ACWY Vaccines in Children
  ClinicalTrials.gov Identifier: NCT00228917 - Completed
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Haemophilus Infections; Meningococcal Infections
  
• Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-Dose Primary Vaccination With the DTPa-HBV-IPV/Hib Vaccine
  ClinicalTrials.gov Identifier: NCT00289796 - Completed
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Poliomyelitis; Hib Disease
  
• Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.
  ClinicalTrials.gov Identifier: NCT00317135 - Completed
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Hib Diseases; Neisseria Meningitidis Serogroups A & C Diseases
  
• Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose.
  ClinicalTrials.gov Identifier: NCT00317161 - Completed
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Hib Diseases; Neisseria Meningitidis Serogroups A & C Diseases
  
• Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.
  ClinicalTrials.gov Identifier: NCT00317187 - Completed
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Hib Diseases; Neisseria Meningitidis Serogroups A & C Diseases
  
• Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants
  ClinicalTrials.gov Identifier: NCT00291967 - Completed
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Hib Diseases; Neisseria Meningitidis Serogroups A & C Diseases
  
• Comparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and Safety.
  ClinicalTrials.gov Identifier: NCT00263692 - Completed
  Prophylaxis: Diphtheria, Tetanus, Pertussis, Poliovirus Type 1, Type 2 and Type 3
  
• Assess the Non-Inferiority of GSK Biologicals’ Mencevax™ ACWY (Manufactured by a New Process) vs Mencevax™ ACWY (the Already Existing Vaccine in the Market) When Given as a Single Dose to Subjects Aged 2-30 Yrs
  ClinicalTrials.gov Identifier: NCT00227422 - Completed
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Haemophilus Infections; Meningococcal Infections
  
• To Evaluate Immunogenicity & Safety of GSK Bio’s DTPa-HBV-IPV/Hib (Mixed Vaccine) and DTPa-IPV/Hib + HBV Vaccines
  ClinicalTrials.gov Identifier: NCT00366366 - Completed
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Polio; Haemophilus Influenzae Type B
  
• The Effects of Anti-HIV Therapy on the Immune Systems of Children Infected With HIV
  ClinicalTrials.gov Identifier: NCT00004735 - Completed
  HIV Infections
  
• Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants
  ClinicalTrials.gov Identifier: NCT00161928 - Completed
  Meningitis, Meningococcal
  
• Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at Birth
  ClinicalTrials.gov Identifier: NCT00317122 - Completed
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Hib Diseases; Neisseria Meningitidis Serogroups A & C Diseases
  
• A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328
  ClinicalTrials.gov Identifier: NCT00000943 - Completed
  HIV Infections
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines
  ClinicalTrials.gov Identifier: NCT00004799 - Completed
  Pertussis
  
• Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy Infants
  ClinicalTrials.gov Identifier: NCT00290303 - Completed
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Hib Diseases; Neisseria Meningitidis Serogroups A & C Diseases
  
• Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected with HIV
  ClinicalTrials.gov Identifier: NCT00001119 - Completed
  HIV Infections
  
• Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy
  ClinicalTrials.gov Identifier: NCT00008866 - Completed
  HIV Infections
  
• Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines
  ClinicalTrials.gov Identifier: NCT00008853 - Completed
  Bacterial Infections; Group B Streptococcus
  
• Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00027534 - Completed
  Breast Cancer; Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; Head and Neck Cancer